Could ADHD Shorten Your Lifespan? What Research Says
Could ADHD shorten your lifespan? New research points to higher mortality risks, but prevention, treatment, and coordinated care can make…
U.S. Cancer Death Rates Are Falling: Progress, Disparities and Prevention
Cancer mortality has declined, but progress is uneven. Learn what drives outcomes, where gaps persist, and what patients and health…
FDA Medical AI Regulation: How New Rules Could Change AI Updates in Healthcare
FDA considers a new way to regulate medical AI through pre-approved update plans. Here is what it could mean for…
AI in Hospitals: How Artificial Intelligence Is Changing Patient Care
AI is transforming hospitals faster than most patients realize, changing scheduling, imaging, clinical notes and safety while raising questions about…
Medical AI Trends Shaping Patient Care in 2026
Medical AI trends are moving from pilots to clinical workflows. Here is what providers, patients, and payors should watch as…
Digital Health Is More Than Telehealth: What Counts & How to Use It
Digital health is changing how care is found, delivered, and managed. Learn where apps, virtual care, data, and AI help…
Clinical Trial Diversity: Why Representation Matters for Cancer Drugs
Clinical trial diversity helps research reflect real patients, improves confidence in results, and can make new treatments safer and more…
Hospital-Acquired Infections Are Declining: Why Patient Safety Is Improving
Hospital-acquired infections continue to decline: why patient safety is improving - and what better prevention means for patients, hospitals, and…
Oveporexton Is the First Brain Signaling Restorer, what patients need to know.
Approved in August 2026, the first oral orexin receptor 2 agonist restores orexin signaling for narcolepsy type 1, shifting treatment…
The Peptide Boom Is Bigger Than Weight Loss
The peptide boom reaches far beyond GLP-1 drugs. Here is what peptides are, where evidence stands, and how patients and…